Company Filing History:
Years Active: 2000
Title: Innovations in Photodynamic Therapy by Leslie A Edwards
Introduction
Leslie A Edwards is a notable inventor based in Santa Barbara, CA, who has made significant contributions to the field of medical technology. She is recognized for her innovative approach to photodynamic therapy, particularly in treating highly vascularized tissues. Her work has the potential to transform surgical procedures and improve patient outcomes.
Latest Patents
Leslie A Edwards holds a patent for a method titled "Photodynamic Therapy of Highly Vascularized Tissue." This method involves the intraoperative administration of photodynamic therapy (PDT) to target tissues that are rich in blood vessels. The process begins with the introduction of a photosensitizing agent into the vasculature of the target tissue. Once the photosensitizer is present, the tissue is exposed to phototherapeutic light, which activates the agent and leads to the destruction of the vascular supply to the tissue. This innovative approach eliminates the need for the photosensitizer to accumulate in nonvascular cells before treatment, streamlining the procedure and enhancing its effectiveness.
Career Highlights
Throughout her career, Leslie has focused on advancing medical technologies that address complex health issues. Her work at Miravant Systems, Inc. has been pivotal in developing new therapeutic methods that leverage the principles of photodynamic therapy. With her expertise, she has contributed to the understanding and application of PDT in various medical contexts.
Collaborations
Leslie A Edwards has collaborated with several professionals in her field, including her coworker Daniel R Doiron. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new medical treatments.
Conclusion
Leslie A Edwards is a pioneering inventor whose work in photodynamic therapy represents a significant advancement in medical technology. Her innovative methods have the potential to improve surgical outcomes and provide new treatment options for patients with highly vascularized tissues.